{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:15:15Z","timestamp":1792412115802,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T00:00:00Z","timestamp":1340668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11033-012-1849-8","type":"journal-article","created":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T11:31:21Z","timestamp":1340623881000},"page":"9827-9834","source":"Crossref","is-referenced-by-count":14,"title":["Association of inflammatory chemokine gene CCL2I\/D with bladder cancer risk in North Indian population"],"prefix":"10.1007","volume":"39","author":[{"given":"Vibha","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama Devi","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,26]]},"reference":[{"key":"1849_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.urolonc.2006.10.011","volume":"26","author":"M Franekova","year":"2008","unstructured":"Franekova M, Halasova E, Bukovska E, Luptak J, Dobrota D (2008) Gene polymorphisms in bladder cancer. Urol Oncol 26:1\u20138","journal-title":"Urol Oncol"},{"key":"1849_CR2","first-page":"222","volume":"49","author":"R Sinha","year":"2003","unstructured":"Sinha R, Anderson DE, McDonald SS, Greenwald P (2003) Cancer risk and diet in India. J Postgrad Med 49:222\u2013228","journal-title":"J Postgrad Med"},{"key":"1849_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","volume":"374","author":"DS Kaufman","year":"2009","unstructured":"Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374:239\u2013249","journal-title":"Lancet"},{"issue":"12","key":"1849_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/gb-2006-7-12-243","volume":"7","author":"A Zlotnik","year":"2006","unstructured":"Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7(12):243","journal-title":"Genome Biol"},{"key":"1849_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","volume":"256","author":"D Raman","year":"2007","unstructured":"Raman D, Baugher PJ, Thu YM, Richmond A (2007) Role of chemokines in tumor growth. Cancer Lett 256:137\u2013165","journal-title":"Cancer Lett"},{"issue":"3","key":"1849_CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molmed.2010.01.003","volume":"16","author":"G Lazennec","year":"2010","unstructured":"Lazennec G, Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16(3):133\u2013144","journal-title":"Trends Mol Med"},{"key":"1849_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","volume":"22","author":"A Mantovani","year":"2010","unstructured":"Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22:231\u2013237","journal-title":"Curr Opin Immunol"},{"key":"1849_CR8","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1006\/bbrc.1999.0796","volume":"259","author":"BH Rovin","year":"1999","unstructured":"Rovin BH, Lu L, Saxena R (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:3448","journal-title":"Biochem Biophys Res Commun"},{"key":"1849_CR9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00002030-200403260-00003","volume":"18","author":"EE Nakayama","year":"2004","unstructured":"Nakayama EE, Tanaka Y, Nagai Y, Iwamoto A, Shioda T (2004) A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS 18:729\u2013738","journal-title":"AIDS"},{"key":"1849_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2009.11.009","volume":"21","author":"J Zhang","year":"2010","unstructured":"Zhang J, Patel L, Pienta KJ (2010) CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis. Cytokine Growth Factor Rev 21:41\u201348","journal-title":"Cytokine Growth Factor Rev"},{"key":"1849_CR11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eursup.2008.08.002","volume":"7","author":"M Colombel","year":"2008","unstructured":"Colombel M, Soloway M, Akaza H et al (2008) Epidemiology, staging, grading, and risk stratification of bladder cancer. Eur Urol Suppl 7:618\u2013626","journal-title":"Eur Urol Suppl"},{"issue":"3","key":"1849_CR12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky Hf (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215","journal-title":"Nucleic Acids Res"},{"key":"1849_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1371\/journal.pone.0005168","volume":"4","author":"TS Ahluwalia","year":"2009","unstructured":"Ahluwalia TS, Khullar M, Ahuja M, Kohli HS, Bhansali A, Mohan V, Venkatesan R, Rai TS, Sud K, Singal PK (2009) Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PLoS One 4:51\u201368","journal-title":"PLoS One"},{"key":"1849_CR14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4238\/vol9-2gmr829","volume":"9","author":"KF Narter","year":"2010","unstructured":"Narter KF, Agachan B, Sozen S, Cincin ZB, Isbir T (2010) CCR2-64I is a risk factor for development of bladder cancer. Genet Mol Res 9:685\u2013692","journal-title":"Genet Mol Res"},{"key":"1849_CR15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1189\/jlb.1105633","volume":"79","author":"K Takashi","year":"2006","unstructured":"Takashi K, Hwang T (2006) Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79:639\u2013651","journal-title":"J Leukoc Biol"},{"key":"1849_CR16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/rheumatology\/kel359","volume":"46","author":"H Chinoy","year":"2006","unstructured":"Chinoy H, Salway F, Fertig N, Tait BD, Oddis CV, Ollier WE, Cooper RG (2006) Monocyte chemotactic protein-1 single nucleotide polymorphisms do not confer susceptibility for the development of adult onset polymyositis\/dermatomyositis in UK Caucasians. Rheumatology (Oxford) 46:604\u2013607","journal-title":"Rheumatology (Oxford)"},{"key":"1849_CR17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0344-0338(98)80057-5","volume":"194","author":"T Valkovic","year":"1998","unstructured":"Valkovic T, Lucin K, Krstulja M (1998) Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pract 194:335\u2013340","journal-title":"Pathol Res Pract"},{"key":"1849_CR18","first-page":"3282","volume":"6","author":"T Ueno","year":"2000","unstructured":"Ueno T, Toi M, Saji H (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6:3282\u20133289","journal-title":"Clin Cancer Res"},{"key":"1849_CR19","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11033-010-0225-9","volume":"38","author":"\u0141 Kruszyna","year":"2011","unstructured":"Kruszyna \u0141, Lianeri M, Rubis ZB, Knu\u0142a H, Rybczynska M, Gazdecka GS, Jagodzinski PP (2011) CCL2 22518 A\/G single nucleotide polymorphism as a risk factor for breast cancer. Mol Biol Rep 38:1263\u20131267","journal-title":"Mol Biol Rep"},{"key":"1849_CR20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.urology.2009.04.016","volume":"74","author":"LG V\u00e1zquez-Lavista","year":"2009","unstructured":"V\u00e1zquez-Lavista LG, Lima G, Gabilondo F, Llorente L (2009) Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology 74:414\u2013418","journal-title":"Urology"},{"key":"1849_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-8-20","volume":"8","author":"P Prasad","year":"2007","unstructured":"Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, Thelma BK (2007) Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 8:20","journal-title":"BMC Med Genet"},{"key":"1849_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-3083.2008.02192.x","volume":"69","author":"R Singh","year":"2009","unstructured":"Singh R, Kapoor R, Srivastava A, Mittal RD (2009) Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients. Scand J Immunol 69:51\u201356","journal-title":"Scand J Immunol"},{"key":"1849_CR23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0003319710385335","volume":"62","author":"N Katrancioglu","year":"2011","unstructured":"Katrancioglu N, Manduz S, Karahan O, Yilmaz MB, Sezgin I, Bagci G, Berkan O (2011) The role of the CCR2 gene polymorphism in abdominal aortic aneurysms. Angiology 62:140\u2013143","journal-title":"Angiology"},{"key":"1849_CR24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2407-10-278","volume":"10","author":"K Chatterjee","year":"2010","unstructured":"Chatterjee K, Dandara C, Hoffman M, Williamson AL (2010) CCRr2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women. BMC Cancer 10:278","journal-title":"BMC Cancer"},{"key":"1849_CR25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00002030-200302140-00012","volume":"17","author":"SA Mulherin","year":"2003","unstructured":"Mulherin SA, Brien TRO, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS (2003) International Meta-Analysis of HIV Host Genetics. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS 17:377\u2013387","journal-title":"AIDS"},{"key":"1849_CR26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jneuroim.2003.09.003","volume":"145","author":"R Miyagishi","year":"2003","unstructured":"Miyagishi R, Niino M, Fukazawa T, Yabe I, Kikuchi S, Tashiro K (2003) C\u2013C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol 145:135\u2013138","journal-title":"J Neuroimmunol"},{"key":"1849_CR27","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ygyno.2004.11.028","volume":"9","author":"A Coelho","year":"2005","unstructured":"Coelho A, Matos A, Catarino R, Pinto D, Pereira D, Lopes C, Medeiros R (2005) Protective role of the polymorphism CCR2-64I in the progression from squamousintraepithelial lesions to invasive cervical carcinoma. Gynecol Oncol 9:760\u2013764","journal-title":"Gynecol Oncol"},{"key":"1849_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/jmg.2003.013649","volume":"41","author":"A Zafiropoulos","year":"2004","unstructured":"Zafiropoulos A, Crikas N, Passam AM, Spandidos DA (2004) Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 41:59","journal-title":"J Med Genet"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1849-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-1849-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-1849-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T03:12:26Z","timestamp":1559358746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-1849-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,26]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1849"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-1849-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,26]]}}}